Page 3 - Riccardo Perfetti News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Riccardo perfetti. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Riccardo Perfetti Today - Breaking & Trending Today

Applied Therapeutics (NASDAQ:APLT) Shares Gap Down to $6.75

Applied Therapeutics (NASDAQ:APLT) Shares Gap Down to $6.75
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Leslied Funtleyder , Riccardo Perfetti , Leerink Partnrs , Vr Adviser , Therapeutics Inc , Armistice Capital , Franklin Resources Inc , Applied Therapeutics , Get Free Report , Therapeutics Stock Down , Point Capital , Applied Therapeutics Daily ,

Functional Improvement Seen With Govorestat in SORD Deficiency Trial

The phase 3 double-blind, placebo-controlled INSPIRE trial included 56 patients aged 16 to 55 years with genetically-confirmed SORD deficiency ....

Riccardo Perfetti , Health Index , Chief Medical Officer ,

Applied Therapeutics (APLT) Announces Positive Results from 12-month Interim Analysis of Govorestat (AT-007) in the Ongoing INSPIRE Phase 3 Trial in SORD Deficiency

Applied Therapeutics (APLT) Announces Positive Results from 12-month Interim Analysis of Govorestat (AT-007) in the Ongoing INSPIRE Phase 3 Trial in SORD Deficiency
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Riccardo Perfetti , Shoshana Shendelman , Health Index , University Of Iowa Medical Center , Therapeutics Inc , Drug Administration , Applied Therapeutics , Sorbitol Dehydrogenase , Aldose Reductase Inhibitor , New Drug Application , Analysis Results , Chief Medical Officer , Michael Shy , Neuromuscular Medicine , Carver College , Iowa Medical Center , Principal Investigator ,

AT-001 Fails to Achieve Significance for Primary Endpoint in ARISE-HF

Applied Therapeutics announced topline results from ARISE-HF on January 04, 2023 and plans to present full results at an upcoming medical conference. ....

United States , James Januzzi , Riccardo Perfetti , Institute James Januzzi , Hutton Family Professor , Massachusetts General , Applied Therapeutics , North America , Chief Medical Officer ,

Applied Therapeutics fails heart disease phase 3, seeks partner to bring molecule to market

Applied Therapeutics fails heart disease phase 3, seeks partner to bring molecule to market
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Riccardo Perfetti , Applied Therapeutic ,